New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

HRTSvsETF 2ETF Comparison

ETF 1
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
-1.28%
VS
ETF 2
Suggested HRTS comparisons

Choose a second ETF to run a side-by-side ETF comparison with HRTS, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HRTS performance and flow charts

Performance

0.01.02.03.04.05.06.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-1.4 M-1.2 M-1 M-0.8 M-0.6 M-0.4 M-0.2 M0 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
HRTS
ETF 2
+0.22%
-7.83%
-7.09%
+15.13%
n/a
n/a
Flows
HRTS
ETF 2
-$1M
-$4M
-$2M
-$12M
-–
-–
Volatility and drawdown
3M1Y3Y5Y
Volatility
HRTS
ETF 2
+16.39%
+16.33%
n/a
n/a
Max drawdown
HRTS
ETF 2
-9.68%
-10.68%
n/a
n/a
Max drawdown duration
HRTS
ETF 2
59d
112d
n/a
n/a
Trading data

Create an account to view trading data

Join for free
HRTS
ETF 2
Last sale
4/29/2026 at 6:04 PM
$32.74
Previous close
04/29/2026
$33.15
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Advertisement
Main metrics
Last update 4/29/2026 at 6:04 PM
Live
Closed
HRTS
ETF 2
Last price
$32.74
1D performance
-1.22%
AuM$48.91 M
E/R0.99%
Characteristics
HRTS
ETF 2
Management strategyActive
ProviderTema
Benchmark-
N° of holdings38
Asset class-
Trailing 12m distribution yield
Join
Join
Inception dateNovember 21, 2023
ESGNo
Advertisement
Exposure

Countries

HRTS
USA
82.47%
Other
17.53%
ETF 2

Sectors

HRTS
Health Care
87.86%
Other
12.14%
ETF 2
Advertisement

Diversification

HRTS

Total weight of top 15 holdings out of 15

61.52%
ETF 2

Top 15 holdings

Data as of March 31, 2026
HRTS
LILLY
9.70%
JOHNSON&JOHNSON
4.97%
US7711951043
4.94%
ASTRAZENECA
4.91%
MERCK & CO INC
4.46%
THERMO FISHER SCIENTIFIC
4.06%
UNITEDHEALTH GRP
3.79%
GILEAD SCIENCES
3.66%
NOVARTIS
3.52%
VERTEX PHARMACEUTICALS
3.30%
ABBOTT LABS
3.26%
ABBVIE
3.00%
BRIDGEBIO PHARMA
2.85%
DANAHER
2.81%
BRISTOL-MYERS SQUIBB
2.29%
ETF 2
Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up